viewTesla Inc

FBI looking into Tesla’s Model 3 productions numbers, says WSJ

Federal agents are reportedly reviewing Model 3 production numbers as part of a criminal investigation

Tesla charger
Tesla confirmed that it received a voluntary request for documents about its public guidance

The US Federal Bureau of Investigations is taking a look into Tesla Inc’s (NASDAQ:TSLA) Model 3 production numbers, according to a Wall Street Journal report published Friday.

Federal agents are allegedly reviewing Model 3 production numbers dating back to early 2017 as part of a criminal investigation, as per the report.

READ: Tesla beats the Street and delivers; posts profit and ramps up Model 3 production

Tesla released a statement in response, confirming that it received a voluntary request for documents about its public guidance for the Model 3 and had cooperated.

“Tesla's philosophy has always been to set truthful targets – not sandbagged targets that we would definitely exceed and not unrealistic targets that we could never meet. While Tesla gets criticized when it is delayed in reaching a goal, it should not be forgotten that Tesla has achieved many goals that were doubted by most,” stated Tesla.

The company said it has not received a subpoena, a request for testimony or additional documents, or any other formal process from the Department of Justice.

Shares of Tesla were unfazed, up more than 4% to US$327.61 in Friday afternoon trading.


Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee


Quick facts: Tesla Inc

Price: 1119.63 USD

Market: NASDAQ
Market Cap: $207.66 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



OptiBiotix Health CEO updates on new deal with Actial Farmaceutica and...

OptiBiotix Health's (LON:OPTI) Stephen O'Hara caught up with Proactive London's Andrew Scott following the news they've signed a distribution deal covering Australia, New Zealand, Indonesia, and Thailand for its cholesterol and blood pressure reducing dietary supplements, CholBiome and CholBiome...

15 hours, 2 minutes ago

2 min read